220100-05-0
Chemical Structure
α7 Nicotinic receptor agonist-1
- CAS No.: 220100-05-0
- Formula:C13H17N3O
- Molecular Weight:231.29
IUPAC Name: 3'H-4-azaspiro[bicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridin]-5'-amine
InChIKey: SWFYVZKNABTMPR-ZDUSSCGKSA-N
SMILES: NC1=CN=C2OC3(CC2=C1)C(CC4)CCN4C3
Biological Activity: α7 Nicotinic receptor agonist-1 (Preparation 5) is an α7 nAChR agonist. α7 Nicotinic receptor agonist-1 can be used in studies of psychiatric disorders (such as schizophrenia, manic or hypomanic depression and anxiety disorders) and intellectual disorders (such as alzheimer's disease, learning deficits, cognitive deficits, attention deficits, memory loss, lewy body dementia and attention deficit hyperactivity disorder)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
α7 Nicotinic receptor agonist-1 | 99.70% | α7 Nicotinic receptor agonist-1 (Preparation 5) is an α7 nAChR agonist. α7 Nicotinic receptor agonist-1 can be used in studies of psychiatric disorders (such as schizophrenia, manic or hypomanic depression and anxiety disorders) and intellectual disorders (such as alzheimer's disease, learning deficits, cognitive deficits, attention deficits, memory loss, lewy body dementia and attention deficit hyperactivity disorder). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
